GlaxoSmithKlineThe Impact of Medicines: Sustainability in Environment, Health and Safety Report 2002
Reporting Front PageDownloads
EHS 2002 home

About this report

Executive statements

Framework

EHS and EHM vision

Environment, health and safety policy

Planning

Organisation
CEHS
EHM
Partnerships

Management systems

Programmes

Audit

Stakeholder communication

Reward and recognition

Issues

Performance

Verification statement

Index

Corporate environment, health and safety organisation
Previous
Next
 
 

The EHS Regulatory Advocacy and Strategy team identifies emerging issues and works with government and regulatory bodies to influence the development of regulations. It also co-ordinates the EHS Plan for Excellence that will enable GSK to achieve its EHS aspirations.

The EHS Product Stewardship team promotes the ethical management of environment, health and safety throughout the life cycles of GSK products. This group champions sustainable EHS practices and works with R&D and New Product Supply (NPS) to identify potential EHS life cycle issues early in the development process. Once the team assesses EHS issues, they recommend measures to mitigate, control, and manage EHS risks. The team also recommends to R&D strategies for developing manufacturing processes that use resources efficiently and that minimise emissions. And they help by developing and promoting innovative tools, systems and methodologies.

The Hazard Assessment and Communication team identifies and communicates environment, health and safety hazards and risk information associated with research, development and manufacture of GSK products. This team focuses on R&D materials in the Pharmaceuticals, Biologicals and Consumer Healthcare businesses and especially on all new GSK products. Its task is to provide information that will support safe and effective controls for protection of employees and the environment. In 2002, the team began to systematically identify and fill gaps in hazard information resulting from merger-related transfers of products within the manufacturing network. The goal is to ensure consistent, high-quality hazard information for all GSK materials.

The EHS Global Business Support team develops partnerships and cost effective solutions that support GSK in managing key EHS risks. The Global Business Support team members serve as Corporate Environment, Health and Safety's lead contacts with senior management and EHS staff in each global manufacturing supply chain. This team also provides internal consulting and supports programme management by offering technical specialists in the following EHS disciplines: environmental engineering, process safety, safety engineering, driver safety, occupational hygiene and transportation of dangerous materials.

The EHS Global Audit team delivers an internal audit programme, in co-ordination with Employee Health Management, for all manufacturing and supply, research & development and key office and warehouse locations. In addition, this team performs risk-based assessments of key contract manufacturers and suppliers and EHS due diligence assessments for acquisitions and divestitures. In all cases the aim is to ensure that EHS risks and impacts are managed effectively and to identify opportunities to reduce risks and contribute to continuous improvement.

The EHS Global Impact Assessment and Reporting team collects and analyses data from all operations for reporting to internal and external stakeholders. It evaluates data contributed by all GSK operations and uses the information to assess the effectiveness of EHS programmes and drive continuous improvement. The team also provides EHS information management software that can be used to manage EHS programmes and measure improvement and progress to targets. In addition, it manages EHS reward, recognition and awareness programmes that are the parts of the overall GSK EHS Framework devoted to motivating employees, raising awareness and driving continuous improvement.

Janice Whitaker

"EHS is closely aligned with Quality, sharing the basic principles of management systems and continuous improvement. Moreover, the success of the Quality programme (ie right first time, lower rejects, etc.) directly affects the success of the EHS programme (ie less waste, safer working conditions). Both Quality and EHS are top business priorities." Janice Whitaker, SVP, Quality, Global Manufacturing and Supply



Previous

Next


Top


EHS 2002 Home | Reporting Front Page | Downloads | Main Site

 
Updated July 21, 2003 - © 2005 GlaxoSmithKline - All Rights Reserved
Legal Notices - Privacy Statement